0001231919-24-000084.txt : 20241015 0001231919-24-000084.hdr.sgml : 20241015 20241015160424 ACCESSION NUMBER: 0001231919-24-000084 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20241015 DATE AS OF CHANGE: 20241015 EFFECTIVENESS DATE: 20241015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526844 FILM NUMBER: 241371848 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 D 1 primary_doc.xml X0708 D LIVE 0001740279 IN8BIO, INC. EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY NEW YORK 10118 (646) 600-6438 DELAWARE Incysus Therapeutics, Inc. Corporation true William Ho c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Director Patrick McCall c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Alan S. Roemer c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Peter Brandt c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Emily R. Fairbairn c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Jeremy Graff c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Luba Greenwood c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Travis Whitfill c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Corinne Epperly c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Director Lawrence Lamb c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Kate Rochlin c/o IN8bio, Inc. Empire State Build 350 5th Ave Ste 5330 New York NY NEW YORK 10118 Executive Officer Biotechnology Decline to Disclose 06c false 2024-10-04 false true true true false 0 Newbridge Securities Corporation 104065 None None 1200 North Federal Highway, Suite 400 Boca Raton FL FLORIDA 33432 All States false 12379983 12379983 0 false 73 742799 0 This does not include $65,000 of out of pocket expenses that the Issuer reimbursed Newbridge Securities Corporation. 0 false IN8BIO, INC. /s/ Patrick McCall Patrick McCall Chief Financial Officer 2024-10-15